Development of ambulatory arterio-venous carbon dioxide removal (AVCO 2R): The downsized gas exchanger prototype for ambulation removes enough CO2 with low blood resistance

ASAIO Journal

Volumn 51, Issue 4, 2005, Pages 385-389

  Wang, Dongfang ^a   Lick, Scott D ^a   Campbell, Kelly M ^a   Loran, David B ^a   Alpard, Scott K ^a   Zwischenberger, Joseph B ^a   Chambers, Sean D ^b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b MC3 Inc   (United States)

Author keywords

Arterio Venous Carbon Dioxide Removal; Carbon Dioxide Retention; COPD; Extracorporeal Gas exchange

Indexed keywords

BIOMEDICAL ENGINEERING; BLOOD VESSELS; CARBON DIOXIDE; HEMODYNAMICS; POLYMERS; REMOVAL;

ARTERIO-VENOUS CARBON DIOXIDE REMOVAL; ARTERIOVENOUS SHUNT; BLOOD FLOW RATE; GAS EXCHANGERS;

BLOOD;

CARBON DIOXIDE;

ANIMAL EXPERIMENT; ARTERIAL CARBON DIOXIDE TENSION; ARTERY BLOOD FLOW; ARTERY CATHETERIZATION; ARTICLE; BLOOD GAS ANALYSIS; CALCULATION; CARBON DIOXIDE MEASUREMENT; CAROTID ARTERY; CONTROLLED STUDY; DEVICE; EQUIPMENT DESIGN; EXTRACORPOREAL CIRCULATION; FEMALE; GAS EXCHANGE; GAS FLOW; HEMODYNAMIC MONITORING; NONHUMAN; SHEEP; VENOUS BLOOD;

ANIMALS; ARTERIOVENOUS SHUNT, SURGICAL; CARBON DIOXIDE; CAROTID ARTERIES; CATHETERS, INDWELLING; EVALUATION STUDIES; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; JUGULAR VEINS; MOTOR ACTIVITY; PULMONARY GAS EXCHANGE; SHEEP; TIME FACTORS; VASCULAR RESISTANCE;

EID: 23044499940     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mat.0000176140.19621.55     Document Type: Article

References (25)

1. Mannino DM: COPD: Epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. Chest 121: 121S-126S, 2002.
2. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC: Chronic obstructive pulmonary disease surveillance-United States, 1971-2000. Respir Care 47: 1184-1199, 2002.
3. Partridge MR: Patients with COPD: Do we fail them from beginning to end? Thorax 58: 373-375, 2003.
4. Sin DD, Stafinski T, Ng YC, Bell NR, Jacobs P: The impact of chronic obstructive pulmonary disease on work loss in the United States. Am J Respir Crit Care Med 165: 704-707, 2002.
5. Strassels SA: Economic consequences of chronic obstructive pulmonary disease. Curr Opin Pulm Med 5: 100-104, 1999.
6. Strassels SA, Smith DH, Sullivan SD, Mahajan PS: The costs of treating COPD in the United States. Chest 119: 344-352, 2001.
7. Sullivan SD, Ramsey SD, Lee TA: The economic burden of COPD. Chest 117: 5S-9S, 2000.
8. Fishman A, Martinez F, Naunheim K, et al: A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 348: 2059-2073, 2003.
9. Organ Procurement and Transplantation Network. Lung Kaplan-Meier median waiting times for registrations listed: 1996-2001. Available at: http://www.optn.org/latestData/rptStrat.asp.2004. 2004.
10. Brunston Jr., RL, Tao, W, Bidani A, Alpard SK, Traber DL, Zwischenberger JB: Prolonged hemodynamic stability during arteriovenous carbon dioxide removal for severe respiratory failure. J Thorac Cardiovasc Surg 114: 1107-1114, 1997.
11. Hirschl RB, Conrad S, Kaiser R, et al: Partial liquid ventilation in adult patients with ARDS: A multicenter phase I-II trial. Adult PLV Study Group. Ann Surg 228: 692-700, 1998.
12. Zwischenberger JB: Advances in the management of respiratory failure: Overview. ASAIO 44: 222, 1998.
13. Zwischenberger JB, Conrad SA, Alpard SK, Grier LR, Bidani A: Percutaneous extracorporeal arteriovenous CO2 removal for severe respiratory failure. Ann Thorac Surg 68: 181-187, 1999.
14. Sliwinski P, Macklem PT: Inspiratory muscle dysfunction as a cause of death in COPD patients. Monaldi Arch Chest Dis 52: 380-383, 1997.
15. Tao W, Brunston Jr., RL, Bidani, A, et al: Significant reduction in minute ventilation and peak inspiratory pressures with arteriovenous CO2 removal during severe respiratory failure. Crit Care Med 25: 689-695, 1997.
16. Brunston Jr., RL Zwischenberger, JB, Tao W, Cardenas Jr., VJ Traber, DL, Bidani A: Total arteriovenous CO2 removal: simplifying extracorporeal support for respiratory failure. Ann Thorac Surg 64: 1599-604, 1997.
17. Zwischenberger JB, Alpard SK, Tao W, Deyo DJ, Bidani A: Percutaneous extracorporeal arteriovenous carbon dioxide removal improves survival in respiratory distress syndrome: a prospective randomized outcomes study in adult sheep. J Thorac Cardiovasc Surg 121: 542-551, 2001.
18. Wang D, Lick S, Alpard SK, et al: Toward ambulatory arteriovenous CO2 removal: initial studies and prototype development. ASAIO J 49: 564-567, 2003.
19. Kawahito S, Motomura T, Glueck J, Nosé Jr., Y: Development of a new hollow fiber silicone membrane oxygenator for ECMO: The recent progress. Ann Thorac Cardiovasc Surg 8: 268-274, 2002.
20. Kawahito S, Haraguchi S, Maeda T, et al: Preclinical evaluation of a new hollow fiber silicone membrane oxygenator for pediatric cardiopulmonary bypass: ex-vivo study. Ann Thorac Cardiovasc Surg 8: 7-11, 2002.
21. Kawahito S, Maeda T, Motomura T, et al: Feasibility of a new hollow fiber silicone membrane oxygenator for long-term ECMO application. J Med Invest 49: 156-162, 2002.
22. Maeda T, Iwasaki A, Kawahito S, et al: Preclinical evaluation of a hollow fiber silicone membrane oxygenator for extracorporeal membrane oxygenator application. ASAIO J 46: 426-430, 2000.
23. Motomura T, Maeda T, Kawahito S, et al: Extracorporeal membrane oxygenator compatible with centrifugal blood pumps. Artif Organs 26: 952-958, 2002.
24. Nakata K, Maeda T, Murabayashi S, et al: Development of a new silicone membrane oxygenator for ECMO. Ann Thorac Cardiovasc Surg 6: 373-377, 2000.
25. Peek GJ, Killer HM, Reeves R, Sosnowski AW, Firmin RK: Early experience with a polymethylpentene oxygenator for adult extracorporeal life support. ASAIO J 48: 480-482, 2002.